A stronger 7.2 mg dose of Wegovy wins FDA approval after a 54-day review, promising greater weight loss for eligible patients.
Knowable Magazine reports on low-protein diets, suggesting they may extend lifespan in mice by lowering growth signals and improving metabolic health.